Abstract
When the opioid crisis struck the United States in the early twenty-first century, news reports described it as a new and unprecedented phenomenon: led by Purdue Pharma and its blockbuster Oxy-Contin, Big Pharma’s matchless retail supply chain had brought addiction to white suburbs that had long
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
